Myo Inositol Hexanicotinate is a synthetic nicotinic acid derivative and vitamin B3 analogue primarily indicated for the treatment of diabetic neuropathy and panic disorder. By modulating nicotinic acetylcholine… Read more
Myo Inositol Hexanicotinate is a synthetic nicotinic acid derivative and vitamin B3 analogue primarily indicated for the treatment of diabetic neuropathy and panic disorder. By modulating nicotinic acetylcholine receptors, it helps alleviate nerve pain and manage anxiety symptoms. This category provides access to essential reference standards for the API, as well as critical analytical tools for impurity profiling and pharmacokinetic studies. Laboratory professionals rely on these high-quality materials, including process-related impurities such as mono- and di-nicotinoyl inositol esters and degradation products like myo-inositol and nicotinic acid, to conduct rigorous method validation. Additionally, stable isotope labelled versions of the compound are available to facilitate precise quantitative analysis and support quality control protocols, ensuring the accuracy and reliability of analytical measurements throughout the pharmaceutical development lifecycle.